Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven M Larson

Showing results (281-290 of 300) with videos related to

Pageof 30
Sort By:
Molecular Pharmaceutics|May 19, 2026
Establishment of <sup>68</sup>Ga-DOTA-Based Pretargeted RadioimmunodiagnosisDarren R Veach, Daniela Burnes Vargas, Baharul Islam, et al.
Theranostics|October 14, 2020
Alpha radioimmunotherapy using <sup>225</sup>Ac-proteus-DOTA for solid tumors - safety at curative dosesSarah M Cheal, Michael R McDevitt, Brian H Santich, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 21, 2024
Theranostic GPA33-Pretargeted Radioimmunotherapy of Human Colorectal Carcinoma with a Bivalent <sup>177</sup>Lu-Labeled RadiohaptenBrett A Vaughn, Sang-Gyu Lee, Daniela Burnes Vargas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2020
First-in-Human Trial of Epichaperome-Targeted PET in Patients with CancerMark P S Dunphy, Christina Pressl, Nagavarakishore Pillarsetty, et al.
Pediatric Blood & Cancer|September 24, 2017
A phase II study of radioimmunotherapy with intraventricular <sup>131</sup> I-3F8 for medulloblastomaKim Kramer, Neeta Pandit-Taskar, John L Humm, et al.
The Journal of Clinical Endocrinology and Metabolism|September 27, 2018
Vemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid CancersLara A Dunn, Eric J Sherman, Shrujal S Baxi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 22, 2014
⁸⁹Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancerNeeta Pandit-Taskar, Joseph A O'Donoghue, Volkan Beylergil, et al.
Molecular Systems Biology|February 17, 2017
Recurrent patterns of DNA copy number alterations in tumors reflect metabolic selection pressuresNicholas A Graham, Aspram Minasyan, Anastasia Lomova, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 19, 2007
NCCN task force report: positron emission tomography (PET)/computed tomography (CT) scanning in cancerDonald A Podoloff, Ranjana H Advani, Craig Allred, et al.
Science Translational Medicine|December 2, 2016
Internalization of secreted antigen-targeted antibodies by the neonatal Fc receptor for precision imaging of the androgen receptor axisDaniel L J Thorek, Philip A Watson, Sang-Gyu Lee, et al.
Pageof 30

Showing results (281-290 of 300) with videos related to

Sort By:
Pageof 30
Molecular Pharmaceutics|May 19, 2026
Establishment of <sup>68</sup>Ga-DOTA-Based Pretargeted RadioimmunodiagnosisDarren R Veach, Daniela Burnes Vargas, Baharul Islam, et al.
Theranostics|October 14, 2020
Alpha radioimmunotherapy using <sup>225</sup>Ac-proteus-DOTA for solid tumors - safety at curative dosesSarah M Cheal, Michael R McDevitt, Brian H Santich, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 21, 2024
Theranostic GPA33-Pretargeted Radioimmunotherapy of Human Colorectal Carcinoma with a Bivalent <sup>177</sup>Lu-Labeled RadiohaptenBrett A Vaughn, Sang-Gyu Lee, Daniela Burnes Vargas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2020
First-in-Human Trial of Epichaperome-Targeted PET in Patients with CancerMark P S Dunphy, Christina Pressl, Nagavarakishore Pillarsetty, et al.
Pediatric Blood & Cancer|September 24, 2017
A phase II study of radioimmunotherapy with intraventricular <sup>131</sup> I-3F8 for medulloblastomaKim Kramer, Neeta Pandit-Taskar, John L Humm, et al.
The Journal of Clinical Endocrinology and Metabolism|September 27, 2018
Vemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid CancersLara A Dunn, Eric J Sherman, Shrujal S Baxi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 22, 2014
⁸⁹Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancerNeeta Pandit-Taskar, Joseph A O'Donoghue, Volkan Beylergil, et al.
Molecular Systems Biology|February 17, 2017
Recurrent patterns of DNA copy number alterations in tumors reflect metabolic selection pressuresNicholas A Graham, Aspram Minasyan, Anastasia Lomova, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 19, 2007
NCCN task force report: positron emission tomography (PET)/computed tomography (CT) scanning in cancerDonald A Podoloff, Ranjana H Advani, Craig Allred, et al.
Science Translational Medicine|December 2, 2016
Internalization of secreted antigen-targeted antibodies by the neonatal Fc receptor for precision imaging of the androgen receptor axisDaniel L J Thorek, Philip A Watson, Sang-Gyu Lee, et al.
Pageof 30